Skip to main content

Table 5 Human studies reporting number of CD3+ (T cells) and CD11b+ (granulocytes/phagocytes) in muscle

From: Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: association with radiologically defined muscle mass and gene expression

Study Subjects Age (years) Sample size Muscle group Number of CD3+/mm2 Number of CD11b+/mm2
Anoveros-Barrera et al. (current study) Cancer population, men and women 64 (38–81) n = 30 rectus abdominis 12.3 (1.6–33.3) 3 (0–13)
Pandya et al. [11] Myopathy, men and women 64 (43–74) n = 16 VA and TA 13.5 (0.5–963) N/A
Dorph et al. [12] Myopathy, men and women 58 (38–76) n = 11 VA and TA Symptomatic muscles: 58.1 (0.5–159.8)
Asymptomatic muscles: 55.9 (1.1–126.8)
N/A
Healthy volunteers, men and women 51 (47–56) n = 6 VL and TA 1.8 (0.4–5.0)
Englund et al. [7] Myopathy, men and women. 46 (26–64) n = 11 VL 3 (0–7) 1 (0–10)
Healthy volunteers, men and women 27 (22–46) n = 7 VL 1 (0–2) 0 (0–1)
  1. Values reported as median (minimum-maximum). Myopathy: polymyositis and dermatomyositis. VL vastus lateralis, TA tibialis anterior, N/A not assessed